Welcome to the Empowered Patient Podcast with Karen Jagoda. This show is a window into the latest innovations in applying generative AI, novel therapeutics and vaccines, and the changing dynamics in the medical and healthcare environment. One focus is on how providers, pharmaceutical companies, and payers are empowering patients. In addition, conversations are often about how providers, care facilities, pharmaceutical companies, and payers are being empowered by technology to improve patient outcomes and reduce friction across the healthcare landscape.
Popular Topics
- Virtual and digital health
- Use of AI, ML, and LLM in healthcare and drug discovery, development, trials
- Value-based healthcare
- Precision and stratified medicine
- Integration of digital technology into existing workflow and procedures
- Next-generation immuno, cell, and gene therapies
- Vaccines
- Biomarkers, sequencing, and imaging
- Rare diseases
- MedTech and medical devices
- Clinical trials
- Addressing Social Determinants of Health
- Treating chronic conditions like obesity and pain
- Clinician and staff burnout
The audience includes life science leaders, researchers, medical professionals, patient advocates, digital health entrepreneurs, patients, caregivers, healthcare solution providers, students, journalists, and investors.
Check out our new EmpoweredPatient.Solutions site where you can quickly search all of the Empowered Patient Podcast interviews by any word or phrase to identify useful resources, potential partners, and insights about the life sciences landscape.
Breakthrough Dual-Chamber Leadless Pacemaker Uses Capsule-Sized Devices and Implant-to-Implant Technology with Vish Charan Abbott TRANSCRIPT
Download PDFFeb 7, 2024
Vish Charan, Divisional Vice President of Product Development at Abbott's Cardiac Rhythm Management Business, explains some of the limitations of traditional pacemakers implanted in the chest with long wires connecting the pacemaker to the heart. Abbott has developed the AVEIR DR system, a dual-chamber leadless pacemaker that uses implant-to-implant technology to send electrical impulses between the upper and lower chambers of the heart. The i2i technology allows these capsule-size devices to be implanted directly in the heart with the ability to communicate to synchronize the heart rhythm.
Vish explains, "What we can do right now, is to get a very, very small access into the veins in the leg, and from the veins in the leg with a very small access, we're able to deploy these capsule-size pacemakers directly into the heart with a long tube. We call that a catheter. But that is how they're deployed. So, you don't have a surgical pocket. You don't have a big cut open in your chest, and the device is implanted in your upper chest. All you have now is a surgical axis in your leg, and you have two capsule-sized devices, which are much smaller than two AAA batteries directly implanted in the heart."
"So, the technology involved with AVEIR DR is where you have these two capsule-sized devices directly implanted in the upper and lower chambers of the heart. The two chambers of the heart need to operate in synchrony. What we can do is that in the upper and the lower chambers of the heart, which are the atrium and the ventricle, we can sense and pace directly in those chambers."
"But the good thing and the technological advantage of this product is they communicate with each other. The communication scheme is what we call i2i technology, where we are sending electrical impulses between the upper and the lower chamber devices. These are electrical impulses that are very, very short, and very small, which cannot be felt by the person who has a device, but that is sufficient for the devices to register information between the upper and lower device and able to operate in synchrony. And this synchrony is extremely important for the person to get back to their normal heart rhythm."
#Abbott #AVEIRDR #Pacemaker #LeadlessPacemaker #DualChamberPacemaker #HeartHealth #i2i #ImplanttoImplant
